GHK-Cu, epitalon, NAD+ and the growth-hormone secretagogues — a grounded tour of the compounds studied in the longevity and healthy-aging space, and what the research does and does not yet show.
The healthy-aging category attracts more speculation than almost any other, which is exactly why it deserves a grounded walkthrough. These are the compounds researchers actually study in the longevity context, sorted by what they are and what the evidence currently supports.
GHK-Cu: the copper peptide
GHK-Cu is a copper-binding tripeptide that occurs naturally in the body and declines with age. In research, it is associated with skin remodeling, collagen-related signaling, and wound-repair pathways, which is why it appears so often in the anti-aging conversation. Much of the interesting work is in topical and cellular models; it is a well-characterized molecule with a real research history, though the human longevity claims that get attached to it tend to run ahead of the data.
Epitalon and the telomere question
Epitalon is a short peptide studied for its proposed influence on telomerase activity — the enzyme involved in maintaining the protective caps on the ends of chromosomes. The telomere connection is what drives its popularity in longevity circles. It is worth being honest that much of this work is early-stage and model-based; the mechanism is genuinely interesting, but "studied for a proposed effect" is not the same as "proven to extend anything in humans."
NAD+ and cellular energy
NAD+ is a coenzyme central to cellular energy metabolism, and its levels are known to decline with age. Research interest centers on whether supporting NAD+ availability influences the cellular pathways tied to aging. This is one of the more actively studied areas in the whole longevity field, but it is also one where the gap between compelling cell-biology rationale and demonstrated human outcomes is still wide.
The growth-hormone secretagogues
Compounds like CJC-1295, ipamorelin, and tesamorelin are studied for their interaction with growth-hormone-releasing pathways. In the aging context, the interest is in age-related changes to those pathways. These are distinct molecules with distinct profiles, and they belong in this discussion as a separate mechanistic story from the copper peptides and coenzymes above — not as interchangeable "anti-aging peptides."
The evidence, stated plainly
The healthy-aging category is where mechanism-level plausibility and proven human benefit are furthest apart. Several of these compounds have credible, interesting rationales and real research literatures. Very few have the kind of long-term human outcome data that would justify the boldest claims made about them. Holding both of those facts at once is what separates a serious reader from a hopeful one.
Handling and framing
As with every category here, these are lyophilized research compounds sold for laboratory use only, and each batch ships with a third-party COA confirming identity and purity. The longevity space rewards skepticism more than most. Understand the mechanisms, respect the limits of the evidence, and insist on documentation — that is the healthy way to approach healthy-aging research.
FOR LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE. This content is educational and summarizes research literature; it is not medical advice or a product claim.